SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 4,966.56 |
| Enterprise Value ($M) | 6,347.44 |
| Book Value ($M) | 83.81 |
| Book Value / Share | 0.66 |
| Price / Book | 59.26 |
| NCAV ($M) | -903.04 |
| NCAV / Share | -7.11 |
| Price / NCAV | -5.50 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.17 |
| Return on Assets (ROA) | 0.17 |
| Return on Equity (ROE) | 4.28 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 5.50 |
| Current Ratio | 6.64 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 746.42 |
| Assets | 1,733.27 |
| Liabilities | 1,649.46 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 829.25 |
| Operating Income | 340.07 |
| Net Income | 281.59 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 388.57 |
| Cash from Investing | -96.91 |
| Cash from Financing | -407.99 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Vanguard Group Inc | 10.04 | -1.99 | |
| 13G/A | Artisan Partners Limited Partnership | 5.10 | -6.33 | |
| 13G/A | Invesco Ltd. | 2.10 | -59.98 | |
| 13G/A | BlackRock Inc. | 14.10 | -2.95 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 106,254 | 436,894 | 24.32 | |
| 72,948 | 286,656 | 25.45 | |
| 84,271 | 216,376 | 38.95 | |
| 121,357 | 608,874 | 19.93 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| GOSS – Gossamer Bio, Inc. | GRTS – Gritstone bio, Inc. |
| GTHX – G1 Therapeutics, Inc. | HLVX – HilleVax, Inc. |
| HOWL – Werewolf Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io